- Disease Modifying Antirheumatic Drugs in Rheumatoid Artritis
-
Suh CH
- KMID: 2168064
- Hanyang Med Rev.
- 2005 May;25(2):73-79.
Rheumatoid arthritis (RA) is a chronic progressive disease, affecting an estimated 1% of the population worldwide. Although the optimal care of RA patients requires various modalities, pharmacotherapy remains the cornerstone... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of juvenile rheumatoid arthritis
-
Kim KN
- KMID: 2280906
- Korean J Pediatr.
- 2010 Nov;53(11):936-941.
- doi: 10.3345/kjp.2010.53.11.936
The systematic approach to pharmacologic treatment is typically to begin with the safest, simplest, and most conservative measures. It has been realized that the more rapidly inflammation is under control,... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical Treatment of Rheumatoid Arthritis
-
Lee YH, Song GG
- KMID: 2015016
- J Korean Geriatr Soc.
- 1999 Jun;3(1):7-14.
Rheumatoid arthritis is a chronic inflammatory disease and afflicts approximately 1% of general population. Once considered as a benign non-fatal disease, rheumatoid arthritis is a debilitating condition with a serious... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors Associated with Estimated Glomerular Filtration Rate in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis after Treatment with Biological Disease Modifying Anti-Rheumatic Drugs
-
Lee SW
- KMID: 2418435
- J Korean Med Sci.
- 2018 Jul;33(30):e214.
- doi: 10.3346/jkms.2018.33.e214
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Medical treatment of rheumatoid arthritis (I): Nonsteroidal anti-inflammatory drugs, disease modifying antirheumatic drugs and glucocorticoids
-
Koh EM
- KMID: 2188412
- J Korean Med Assoc.
- 2010 Oct;53(10):871-879.
- doi: 10.5124/jkma.2010.53.10.871
The medical treatment of rheumatoid arthritis has been dramatically improved with the advances of newer disease-modifying antirheumatic drugs (DMARDs) and biologic agents during previous decades. To prevent joint damage, it... -
- CITED
-
- Close
- SHARE
-
- Close
- Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
-
Kwok SK
- KMID: 1794621
- Korean J Intern Med.
- 2014 Sep;29(5):577-579.
- doi: 10.3904/kjim.2014.29.5.577
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Combination of Methotrexate and Leflunomide for Adult-onset Still's Disease: A Case Report and Literature Review
-
Lee EE, Kim MJ, Song YW, Park JK
- KMID: 2471953
- J Rheum Dis.
- 2020 Apr;27(2):116-119.
- doi: 10.4078/jrd.2020.27.2.116
The treatment of adult-onset Still's disease (AOSD) aims to control systemic inflammation and prevent organ damage. Systemic inflammation can be controlled with corticosteroid (CS) monotherapy in most cases. However, symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
- Ultrasonographic Assessment in Rheumatoid Arthritis
-
Kim HR, Yoon CH
- KMID: 2202122
- J Korean Rheum Assoc.
- 2009 Jun;16(2):74-86.
- doi: 10.4078/jkra.2009.16.2.74
The administration of disease-modifying antirheumatic drugs (DMARDs) in the early period of rheumatoid arthritis (RA) is critical for protecting against joint damage and inducing remission. Physicians need to identify patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Paradigm Shifting to Early Treatment of Rheumatoid Arthritis
-
Park MC, Lee SK
- KMID: 2183129
- J Korean Med Assoc.
- 2003 Nov;46(11):965-971.
- doi: 10.5124/jkma.2003.46.11.965
The past decade has greatly enhanced our understanding of rheumatoid arthritis (RA). Not only have new drug therapies become available, but this period has witnessed dramatic changes in treatment strategies... -
- CITED
-
- Close
- SHARE
-
- Close
- Rhupus syndrome
-
Min JK, Lee KA, Kim HR, Kim HY, Lee SH
- KMID: 2129677
- Korean J Intern Med.
- 2015 Jan;30(1):131-131.
- doi: 10.3904/kjim.2015.30.1.131
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
-
Park EJ, Kim H, Jung SM, Sung YK, Baek HJ, Lee J
- KMID: 2471957
- J Rheum Dis.
- 2020 Jan;27(1):4-21.
- doi: 10.4078/jrd.2020.27.1.4
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inflammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion... -
- CITED
-
- Close
- SHARE
-
- Close
- Medical treatment of rheumatoid arthritis (II): current biologic agents and newly developing drugs
-
Kim J, Song YW
- KMID: 2188413
- J Korean Med Assoc.
- 2010 Oct;53(10):880-888.
- doi: 10.5124/jkma.2010.53.10.880
Disease-modifying antirheumatic drugs (DMARD) have been used to treat rheumatoid arthritis (RA). However, they have limited efficacy and a considerable adverse event profile. Excess production of soluble cytokines, including tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in the Treatment of Spondyloarthropathy
-
Yoo DH
- KMID: 2183130
- J Korean Med Assoc.
- 2003 Nov;46(11):972-980.
- doi: 10.5124/jkma.2003.46.11.972
Spondyloarthropathy is a chronic inflammatory disease involving axial joints and peripheral joints, and finally induces ankylosis of the spine. Treatment of spondyloarthropathy including ankylosing spondylitis has many limitations. Nonsteroidal anti-inflammatory... -
- CITED
-
- Close
- SHARE
-
- Close
- Dactylitis in a Patient with Psoriatic Arthritis Treated with Infliximab
-
Kim D, Sohn IW, Kim JJ, Choi YY, Jung KH, Kim TH, Sung YK
- KMID: 2258911
- Korean J Med.
- 2011 Jun;80(Suppl 2):S310-S313.
Dactylitis is a hallmark feature of psoriatic arthritis. It is usually managed with non-steroidal anti-inflammatory drugs and oral corticosteroids. Some cases have been treated successfully with intravenous corticosteroids or some... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Effectiveness of Biologic DMARDs in Rheumatoid Arthritis Patients with Inadequate Response to conventional DMARDs: Using a Bayesian Network Meta-analysis
-
Park SK, Kim HL, Lee MY, Kim A, Lee EK
- KMID: 2226396
- Korean J Clin Pharm.
- 2015 Mar;25(1):9-17.
- doi: 10.0000/kjcp.2015.25.1.9
BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) extend the treatment choices for rheumatoid arthritis patients with insufficient response or intolerance to conventional DMARDs (cDMARDs). These agents have considerable efficacy compared with... -
- CITED
-
- Close
- SHARE
-
- Close
- Recurrent Pneumothorax after Etanercept Therapy in a Rheumatoid Arthritis Patient: A Case Report
-
Kim SH, Choi SJ, Seo YH, Kim JH, Jeong IW, Sohn SB
- KMID: 2172156
- Chonnam Med J.
- 2014 Dec;50(3):115-118.
- doi: 10.4068/cmj.2014.50.3.115
The use of anti-tumor necrosis factor (anti-TNF) agents for rheumatoid arthritis (RA) patients who are refractory to disease-modifying anti-rheumatic drugs is gradually increasing. Etanercept is the first anti-TNF agent to... -
- CITED
-
- Close
- SHARE
-
- Close
- Current concepts in the management of rheumatoid arthritis
-
Tanaka Y
- KMID: 2373796
- Korean J Intern Med.
- 2016 Mar;31(2):210-218.
- doi: 10.3904/kjim.2015.137
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by inflammation and joint destruction that causes significant morbidity and mortality. However, the combined use of methotrexate, a synthetic disease-modifying antirheumatic... -
- CITED
-
- Close
- SHARE
-
- Close
- New Classification Criteria for Rheumatoid Arthritis
-
Song JS
- KMID: 2269212
- Korean J Med.
- 2014 Oct;87(4):383-388.
- doi: 10.3904/kjm.2014.87.4.383
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by joint swelling, joint tenderness, and the destruction of bone and joints. It also has multiple systemic manifestations, resulting in functional... -
- CITED
-
- Close
- SHARE
-
- Close
- Utilization Patterns of Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients
-
Jin XM, Lee J, Choi NK, Seong JM, Shin JY, Kim YJ, Kim MS, Yang BR, Park BJ
- KMID: 1789977
- J Korean Med Sci.
- 2014 Feb;29(2):210-216.
- doi: 10.3346/jkms.2014.29.2.210
This study was conducted to investigate disease-modifying antirheumatic drug (DMARD) utilization in Korean elderly patients with rheumatoid arthritis (RA). We used data from January 1, 2005 to June 30, 2006... -
- CITED
-
- Close
- SHARE
-
- Close
- Tailored Treatment of Ankylosing Spondylitis
-
Kim TJ
- KMID: 2168200
- Hanyang Med Rev.
- 2012 May;32(2):77-82.
- doi: 10.7599/hmr.2012.32.2.77
Ankylosing spondylitis (AS) is a chronic rheumatic disease of the axial skeleton (spine and sacroiliac joints). Only nonsteroidal anti-inflammatory drugs (NSAIDs) and tumor necrosis factor (TNF) alpha inhibitors have currently... -
- CITED
-
- Close
- SHARE
-
- Close
